Natural history of primary IgA nephropathy

被引:154
作者
Berthoux, Franpis C. [1 ,2 ]
Whey, Heshom [1 ,2 ]
Aflani, Aida [1 ,2 ]
机构
[1] CHU St Etienne, Univ N Hosp, Nephrol Dialysis & Renal Transplantat Dept, St Etienne, France
[2] Univ St Etienne, Res Grp Glomerulonephritides, Fac Med, St Etienne, France
关键词
IgA; glomerulonephritis; Berger's disease; natural history;
D O I
10.1016/j.semnephrol.2007.10.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Primary IgA nephropathy (IgAN) is the most frequent type of primary glomerulonephritis worldwide. The characteristic presentation is gross hematuria at the time of an infectious episode. A renal biopsy still is mandatory for the diagnosis. The natural history of the disease is characterized by clinical and pathologic progression over time, which can vary from a few years to more than 50 years. It is possible to make a broad prediction at the time of diagnosis of the long-term (20 years) risk of progressive chronic kidney disease, and then to end-stage renal disease requiring renal replacement therapy (20-year cumulative end-stage renal disease risk range, 14%-39%). The 3 major independent risk factors are arterial hypertension, proteinuria more than 1 g/d, and severe renal histopathologic lesions including hyalinosis, crescents, or defined by histopathologic scoring systems. When any clinical risk factors are present, patients should be targeted closely by appropriate treatments in the following order: (1) precise control of hypertension, (2) control of proteinuria when persisting for greater than 1 g/d, and (3) evidence-based treatment where available for severe lesions. This is a symptomatic treatment strategy because pathogenesis and etiology still remain unclear. © 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:4 / 9
页数:6
相关论文
共 36 条
  • [1] ALAMARTINE E, 1990, CLIN NEPHROL, V34, P45
  • [2] PROGNOSTIC FACTORS IN MESANGIAL IGA GLOMERULONEPHRITIS - AN EXTENSIVE STUDY WITH UNIVARIATE AND MULTIVARIATE ANALYSES
    ALAMARTINE, E
    SABATIER, JC
    GUERIN, C
    BERLIET, JM
    BERTHOUX, F
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (01) : 12 - 19
  • [3] Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142
  • [4] IgA nephropathy
    Barratt, J
    Feehally, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07): : 2088 - 2097
  • [5] Predicting progression in IgA nephropathy
    Bartosik, LP
    Lajoie, G
    Sugar, L
    Cattran, DC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : 728 - 735
  • [6] BERGER J, 1980, NOUV PRESSE MED, V9, P219
  • [7] BERGER J, 1969, TRANSPL P, V1, P939
  • [8] BERGER J, 1968, J UROL NEPHROL, V74, P694
  • [9] BERTHOUX F, 1990, PRESSE MED, V19, P1417
  • [10] BERTHOUX FC, 1982, ACTA GASTRO-ENT BELG, V45, P136